Atypical hemolytic uremic syndrome due to DGKE mutation and response to eculizumab: lessons for the clinical nephrologist

Journal article

Peer reviewed

Danya Husain, Brian Barron, Anya Golkowski Barron, Ibrahim Sandokji, Olivera Marsenic and Jillian K Warejko

Journal of nephrology, Vol.34(4), pp.1331-1335

01/08/2021

PMID: 33751496

Abstract

Antibodies, Monoclonal, Humanized - therapeutic use

Atypical Hemolytic Uremic Syndrome - diagnosis

Atypical Hemolytic Uremic Syndrome - drug therapy

Atypical Hemolytic Uremic Syndrome - genetics

Diacylglycerol Kinase - genetics

Humans

Infant

Male

Mutation

Nephrologists

1 Record Views

Title: Atypical hemolytic uremic syndrome due to DGKE mutation and response to eculizumab: lessons for the clinical nephrologist
Creators - without role: Danya Husain - Yale University
Brian Barron - Yale University
Anya Golkowski Barron - Yale University
Ibrahim Sandokji - Taibah University
Olivera Marsenic - Stanford University
Jillian K Warejko - Taibah University
Publication Details: Journal of nephrology, Vol.34(4), pp.1331-1335
Identifiers: 9930004408331
Academic Unit: Taibah University
Language: English
Resource Type: Journal article